DOCSLIB.ORG

Identifying Appropriate Journals in Which to Publish Original Research on Vaccines Against Human Infectious Diseases Correspondence To

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Identifying Appropriate Journals in Which to Publish Original Research on Vaccines Against Human Infectious Diseases Correspondence To Identifying appropriate journals in which to publish original research on vaccines against human infectious diseases Correspondence to: Daniel Portsmouth Daniel Portsmouth, Baxter BioScience, Vaccine R&D, Baxter BioScience, Austria Austria daniel_portsmouth@ baxter.com Abstract The most effective way of communicating new be of considerable importance to the field. In prac- research findings is by publishing them in a peer- tice, however, the vast majority of manuscripts sub- reviewed journal which is widely read and highly mitted to the top-ranking journals are not accepted respected. To ensure that important new data are for publication. Rejection will mean, in most cases, shared with the appropriate audience in a timely a requirement to re-structure and re-format the manner, a number of important considerations manuscript before it can be submitted to an alterna- need to be taken into account when choosing a suit- tive journal. In the worst case, the manuscript will able journal. This article provides an analysis of jour- have undergone a lengthy review process; this nals which publish original articles describing studies delay may result in a loss of data novelty and the of vaccines against human infectious diseases. A context of the manuscript may need substantial revi- search of PubMed identified over 80 journals sion. Re-writing and updating the manuscript will which recently published vaccine-related studies. involve further lost time and this could result in These journals were filtered according to impact a considerably diminished impact when the article factor and number and percentage of vaccine- is eventually published. This scenario can be related studies published from 2006 to 2010, result- avoided by a more appropriate initial choice of ing in a core of 32 journals which frequently publish target journal. studies of vaccines against human infectious dis- The key processes involved in identifying suitable eases. A survey was then undertaken to gather target journals have been recently described as part additional information with respect to acceptance of a detailed ‘Authors’ submission toolkit’ pub- rate, average time needed from manuscript sub- lished by members of the pharmaceutical industry mission to acceptance and from acceptance to and biomedical journals.1 Important considerations publication. This dataset should provide a useful include matching the focus of your study with that source of metrics which can help ensure that manu- of the journal, assessing whether and how often scripts are submitted to the most appropriate the journal has published similar types of study in journal. the recent past, restrictions on word, figure and table counts, impact factor (IF), rejection/acceptance Keywords: Vaccine, Infectious diseases, Journal rates (ARs), and times between submission, accep- metrics, Impact factor, Acceptance rate tance, and publication. Much of this information can be gathered from journal websites, citation data- bases and individual publications; however, this is a Publishing in a peer-reviewed journal which is cumbersome task and would be impracticable to widely read and highly respected in the scientific undertake for each new submission. The purpose and medical communities is the primary goal of this article is to provide a database of journal when seeking to communicate important new metrics which will help authors to make informed study findings. Readers can expect that data pub- decisions about where to submit manuscripts lished in a high-quality journal will have undergone which focus on original research in the field of vac- rigorous scrutiny and that the study conclusions will cines against human infectious diseases. © The European Medical Writers Association 2012 26 DOI: 10.1179/204748112X13305147722970 Medical Writing 2012 VOL. 21 NO. 1 Portsmouth – Identifying appropriate journals in which to publish original research on vaccines against human infectious diseases Methods [Publication Type]) NOT “retraction of publi- cation” [Publication Type]) NOT “review” To identify an initial list of potential target journals [Publication Type]) NOT “letter”[Publication suitable for an international audience, an advanced Type]) AND “english”[Language]. search for English-language vaccine-related original research articles was done on PubMed2 using the algorithm: These data were then used to calculate an estimate for the proportion of vaccine-related studies as a percentage of all original research studies in each (((((((((((((((((((((((“2006”[Publication Date] : journal (%V). “2010”[Publication Date]) NOT “comment” Three different databases which provide a [Publication Type]) NOT “corrected and repub- measure of journal and article impact were then lished article”[Publication Type]) NOT “dupli- mined to extract the following journal metrics: cate publication”[Publication Type]) NOT Journal Citation Reports 2010 Impact Factor (IF), 5- “editorial”[Publication Type]) NOT “guide- year impact factor (5 Yr IF), and Immediacy line” [Publication Type]) NOT “historical Index,3 Eigen Factor Article Influence (EF AI),4 article”[Publication Type]) NOT “interview” SCImago Journal Rank (SJR) and Cites/doc (CD).5 [Publication Type]) NOT “news”[Publication To distill a core of higher ranking journals which Type]) NOT “published erratum”[Publication regularly publish vaccine-related studies, a ranking Type]) NOT “retracted publication” filter was utilized with the following cut-off criteria: [Publication Type]) NOT “retraction of publi- IF <2.0 OR V < 15 OR %V <0.5% OR (IF < 3.5 AND cation” [Publication Type]) NOT “review” V < 35 AND %V < 3.0). [Publication Type]) NOT “letter”[Publication The abstracts of articles retrieved for the remain- Type]) AND vacc*[Title]) NOT vaccini*[Title]) ing journals with <25 vaccine articles for NOT vaccr*[Title]) NOT vacca*[Title]) NOT 2006–2010 were then manually inspected to vaccinol*[Title]) NOT vaccen*[Title]) NOT remove inappropriate articles such as non-research vaccina[Title]) NOT vaccinal*[Title]) NOT articles, studies which did not actually investigate vaccinos*[Title]) AND “english”[Language]. vaccines, purely epidemiological studies, case studies, historical studies, opinion, surveys, etc. A As a second step, the list of retrieved articles was final manual inspection removed journals which sorted by journal and all journals publishing at publish vaccine studies focusing exclusively or least five articles between 2009 and 2010 (i.e. over almost exclusively on cancer, AIDS, or veterinarian 2 years) were selected. Next, the PubMed algorithm vaccines. ‘ ’ was extended to include AND x [Journal], where Additional information on the journal such as ‘ ’ x represents one of the journals identified in step focus with respect to infectious disease type two, to retrieve an estimate of the number of original (general, viral, non-viral, or diseases primarily research articles published on vaccine-related affecting tropical or developing countries) and studies over the 5-year period from 2006 to 2010 research stage (preclinical or clinical) and abridged (V). To estimate the equivalent total number of orig- aims and scope relevant to vaccine studies were inal research articles published in these journals (T), gathered from journal websites. To gain information the following PubMed search algorithm was used to on AR, time from submission to acceptance, time query each journal: from acceptance to publication, and open access (OA) status/options, a short questionnaire was (((((((((((((((((((((((“2006”[Publication Date] : sent to an email contact on the journal website. To “2010”[Publication Date]) NOT “comment” unify reported time units to half week intervals, [Publication Type]) NOT “corrected and repub- months were converted to weeks by multiplying lished article”[Publication Type]) NOT “dupli- by 4.333, days were converted to weeks by dividing cate publication”[Publication Type]) NOT by 7, and numbers were rounded up or down “editorial”[Publication Type]) NOT “guide- accordingly. When a range was reported, the line” [Publication Type]) NOT “historical median of this range was used. If there was no article”[Publication Type]) NOT “interview” response within 1 month, follow-up telephone [Publication Type]) NOT “news”[Publication calls were made. If these data were not available Type]) NOT “published erratum”[Publication or journals did not respond or were unwilling to Type]) NOT “retracted publication” supply the data, this was recorded as NA. Medical Writing 2012 VOL. 21 NO. 1 27 Portsmouth – Identifying appropriate journals in which to publish original research on vaccines against human infectious diseases Results and discussion readers but the author can pay a fee upfront for the article to be made freely available online) and A total of 2 818 596 original research articles were a small number were online-only journals which estimated to have been published in the 5-year only publish OA articles. period between 2006 and 2010, and, of these, This analysis is intended only as guide and there 15 230 (approximately 0.5%) were judged to be are a number of limitations to the study. The analy- vaccine related, as defined by the respective sis was not sensitive enough to distinguish between PubMed search algorithms. Table 1 describes the all vaccine-related and non-vaccine studies as journals which met all of the criteria to be included demonstrated by the %V score of 77 and 64% for in further analyses after filtering on the basis of IF, Human Vaccines and Vaccines, respectively, which
Load more

Recommended publications
  • CURRICULUM VITAE Floyd L
    CURRICULUM VITAE Floyd L. Wormley Jr., Ph.D. Office of Research and Graduate Studies Texas Christian University TCU Box 297024 Fort Worth, TX 76129 Phone: (817) 257-7104 ADDRESS: 7121 Axis Ct. Fort Worth, TX 76132 Tel: (817) 386-0645, E-mail: [email protected] ACADEMIC TRAINING: 2002-2005 Doctoral Fellowship, Infectious Diseases Duke University Medical Center, Durham, NC Interdisciplinary Research Training Program in AIDS Program in Microbial Pathogenesis of Cryptococcus neoformans Research Project: Study of host-pathogen interactions during Cryptococcus neoformans infection. Fellowship Advisor: John R. Perfect, M.D. 1998-2001 Doctor of Philosophy, Microbiology/Immunology Louisiana State University Health Sciences Center, New Orleans, LA Dissertation Title: Cell Mediated Immunity Against Experimental Candida albicans Vaginitis. Dissertation Advisor: Paul L. Fidel Jr., Ph.D. 1995-1998 Master of Science, Microbiology/Immunology Louisiana State University Health Sciences Center, New Orleans, LA Thesis Title: Evidence for a Unique CD4 Protein on Murine Vaginal CD4+ T Cells. Thesis Advisor: Paul L. Fidel Jr., Ph.D. 1990-1995 Bachelor of Science, Cellular and Molecular Biology Tulane University, New Orleans, LA. EMPLOYMENT: 2019-Present Associate Provost for Research and Dean of Graduate Studies, Texas Christian University, Fort Worth, TX Role and Responsibility – Promote the advancement of research within the institution and administer key compliance programs through which we promote the responsible conduct of research and integrity. I oversee all research policies and procedures, institutional research compliance committees, and research technology and innovation. I also oversee services and programs for those who seek financial support for their scholarly endeavors from inception of idea through submission and award of research/scholarly project.
    [Show full text]
  • Role of Infection and Immunity in Bovine Perinatal Mortality: Part 2
    animals Review Role of Infection and Immunity in Bovine Perinatal Mortality: Part 2. Fetomaternal Response to Infection and Novel Diagnostic Perspectives Paulina Jawor 1,* , John F. Mee 2 and Tadeusz Stefaniak 1 1 Department of Immunology, Pathophysiology and Veterinary Preventive Medicine, Wrocław University of Environmental and Life Sciences, 50-375 Wrocław, Poland; [email protected] 2 Animal and Bioscience Research Department, Teagasc, Moorepark Research Centre, P61 P302 Fermoy, County Cork, Ireland; [email protected] * Correspondence: [email protected] Simple Summary: Bovine perinatal mortality (death of the fetus or calf before, during, or within 48 h of calving at full term (≥260 days) may be caused by noninfectious and infectious causes. Although infectious causes of fetal mortality are diagnosed less frequently, infection in utero may also compromise the development of the fetus without causing death. This review presents fetomaternal responses to infection and the changes which can be observed in such cases. Response to infection, especially the concentration of immunoglobulins and some acute-phase proteins, may be used for diagnostic purposes. Some changes in internal organs may also be used as an indicator of infection in utero. However, in all cases (except pathogen-specific antibody response) non-pathogen-specific responses do not aid in pathogen-specific diagnosis of the cause of calf death. But, nonspecific markers of in utero infection may allow us to assign the cause of fetal mortality to infection and thus Citation: Jawor, P.; Mee, J.F.; increase our overall diagnosis rate, particularly in cases of the “unexplained stillbirth”. Stefaniak, T. Role of Infection and Immunity in Bovine Perinatal Abstract: Bovine perinatal mortality due to infection may result either from the direct effects of Mortality: Part 2.
    [Show full text]
  • Mbio-2016-Casadevall-.Pdf
    Downloaded from EDITORIAL Rigorous Science: a How-To Guide mbio.asm.org Arturo Casadevall,a Founding Editor in Chief, mBio, Ferric C. Fang,b Editor in Chief, Infection and Immunity Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USAa; Departments of Laboratory on January 3, 2017 - Published by Medicine and Microbiology, University of Washington School of Medicine, Seattle, Washington, USAb ABSTRACT Proposals to improve the reproducibility of biomedical research have emphasized scientific rigor. Although the word “rigor” is widely used, there has been little specific discussion as to what it means and how it can be achieved. We suggest that scientific rigor combines elements of mathematics, logic, philosophy, and ethics. We propose a framework for rigor that includes redundant experimental design, sound statistical analysis, recognition of error, avoidance of logical fallacies, and intel- lectual honesty. These elements lead to five actionable recommendations for research education. igor is a prized quality in scientific work. Although the term is ciple, such as Schrödinger’s cat or Maxwell’s demon in physics, or Rwidely used in both scientific and lay parlance, it has not been entirely experimental, as illustrated by Cavendish’s measurement precisely defined (1). Rigor has gained new prominence amid con- of the gravitational constant at the end of the 18th century. How- mbio.asm.org cerns about a lack of reproducibility in important studies (2, 3), an ever, in the biomedical sciences, most research has both theoreti- epidemic of retractions due to misconduct (4), and the discovery cal and experimental aspects. that the published literature is riddled with problematic images (5).
    [Show full text]
  • The 100 Top-Cited Tuberculosis Research Studies
    INT J TUBERC LUNG DIS 19(6):717–722 Q 2015 The Union http://dx.doi.org/10.5588/ijtld.14.0925 The 100 top-cited tuberculosis research studies L.-M. Chen,*† Y.-Q. Liu,* J.-N. Shen,* Y.-L. Peng,* T.-Y. Xiong,* X. Tong,‡ L. Du,*§¶ Y.-G. Zhang*§¶ *West China Hospital, West China Medical School, Sichuan University, Chengdu, †Department of Anaesthesiology, West China Hospital of Sichuan University, Chengdu, ‡Department of Respiratory Medicine, West China Hospital of Sichuan University, Chengdu, §The Periodical Press of West China Hospital, Sichuan University, Chengdu, ¶The Chinese Cochrane Centre, West China Hospital, Sichuan University, Chengdu, China SUMMARY The examination of top-cited studies is a useful method ing author. The United States contributed the largest for identify and monitoring outstanding scientific number of studies, followed by the United Kingdom and research. The objective of this study was to identify France. The institutions with the largest number of and analyse the characteristics of the top 100 cited articles were the Institut National de la Santeetdela´ research studies on tuberculosis (TB) based on the Web Recherche Medicale´ in France and the University of of Knowledge. Overall, the top 100 cited studies were California in the United States. The studies appeared in cited between 366 and 4443 times, and were published 35 journals, with 11 published in Science, followed by between 1995 and 2010, with the largest number of PNAS and NEJM. The majority of TB articles have been publications in 2003 and in 1995. Four studies were published in those medical journals with the highest attributed to a single author and 10 to two authors; the impact factors, and are from the most industrialised number of authors exceeded six in 50 studies.
    [Show full text]
  • Infection and Immunity Volume 51 * January 1986 * Number 1 J
    INFECTION AND IMMUNITY VOLUME 51 * JANUARY 1986 * NUMBER 1 J. W. Shands, Jr., Editor in Chief (1989) University of Florida, Gainesville Phillip J. Baker, Editor (1990) Peter F. Bonventre, Editor (1989) Arthur G. Johnson, Editor (1986) National Institute ofAllergy and University of Cincinnati University of Minnesota, Duluth Infectious Diseases Cincinnati, Ohio Stephan E. Mergenhagen, Editor (1989) Bethesda, Md. Roy Curtiss III, Editor (1990) National Institute of Dental Researcl Edwin H. Beachey, Editor (1988) Washington University Bethesda, Md. VA Medical Center St. Louis, Mo. Memphis, Tenn. EDITORIAL BOARD Leonard C. Altman (1986) Toby K. Eisenstein (1987) F. Kierszenbaum (1987) Catherine Saelinger (1987) Michael A. Apicella (1988) Peter Elsbach (1986) Paul Kolenbrander (1986) Dwayne C. Savage (1987) Roland Arnold (1987) Stanley Falkow (1988) Julius P. Kreier (1986) Irving E. Salit (1986) John B. Bartlett (1988) John R. Finerty (1987) Maurice J. Lefford (1987) Charles F. Schachtele (1988) Joel B. Baseman (1988) Robert Fitzgerald (1986) Thomas Lehner (1986) Julius Schachter (1986) Robert E. Baughn (1987) James D. Folds (1988) Stephen H. Leppla (1988) Gary K. Schoolnik (1987) Gary K. Best (1988) Samuel B. Formal (1986) F. Y. Liew (1988) June R. Scott (1987) Jenefer Blackwell (1988) Peter Gemski (1988) Francis L. Macrina (1988) Philip Scott (1988) Arnold S. Bleiweis (1987) Robert Genco (1988) John Mansfield (1988) Alan Sher (1987) William H. Bowen (1988) Ronald J. Gibbons (1988) Jerry R. McGhee (1988) Gerald D. Shockman (1986) David E. Briles (1988) Emil Gotschlich (1988) Floyd C. McIntire (1988) W. A. Simpson (1988) Robert R. Brubaker (1986) Frank Griffin (1987) Monte Meltzer (1986) Phillip D. Smith (1988) Gerald Byrne (1988) Richard Guerrant (1986) Jiri Mestecky (1986) Ralph Snyderman (1988) Bruce Chassy (1987) Thomas L.
    [Show full text]
  • Journal of Infection and Public Health
    JOURNAL OF INFECTION AND PUBLIC HEALTH The Official Publication of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and Saudi Association for Public Health AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 1876-0341 DESCRIPTION . The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other. The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners. It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.
    [Show full text]
  • A Bibiliometric Analysis of the Journal of Infection and Public Health: 2008–2016
    G Model JIPH-856; No. of Pages 6 ARTICLE IN PRESS Journal of Infection and Public Health xxx (2018) xxx–xxx Contents lists available at ScienceDirect Journal of Infection and Public Health journal homepage: http://www.elsevier.com/locate/jiph A bibiliometric analysis of the Journal of Infection and Public Health: 2008–2016 Erwin Krauskopf Facultad de Ciencias Biologicas, Universidad Andres Bello, Republica 217, Santiago, Chile a r t i c l e i n f o a b s t r a c t Article history: Background: The Journal of Infection and Public Health published its first issue in 2008. The fact that Received 20 November 2017 the journal has been published uninterruptedly as well as its editorial content and the application of a Accepted 5 December 2017 peer-review process to select manuscripts, made the journal eligible to be indexed by databases such as Scopus. This study presents a general overview of the journal from 2008 until 2016 using bibliometric Keywords: indicators to assess its performance. Bibliometric Methods: The data for this study, dating between 2008 and 2016, was extracted from Scopus database. Citation analysis All the information was exported in CSV format to the Sequel Pro software for data analysis. Additionally, Collaboration network collaboration and word co-occurrence networks were generated using VOSviewer. Journal evaluation Results: The total number of documents published between 2008–2016 was 586, of which local authorship (Saudi Arabia) constituted a small share, accounting only for 19.3% (113 documents). Those with foreign authorship (other countries excluding Saudi Arabia) represented 80.7% (473) of the total.
    [Show full text]
  • Clinical Immunology
    CLINICAL IMMUNOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 1521-6616 DESCRIPTION . Clinical Immunology publishes original research on the molecular and cellular bases of immunological disease. The journal also features reviews of timely topics in basic immunology, case reports, and letters to the editor. Research Areas Include: • Ageing • Allergy • Autoimmunity • Biotechnology • Clinical Laboratory Immunology • HIV • Immunodermatology • Immunohematology • Immunotoxicology/Environmental • Infection and Immunity • Mucosal Immunity • Neuroimmunology • Primary Immunodeficiency • Transplantation • Tumor Immunology • Vaccines Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center AUDIENCE . Basic immunologists, researchers in clinical immunology, molecular biologists, cell biologists AUTHOR INFORMATION PACK 1 Oct 2021 www.elsevier.com/locate/yclim 1 IMPACT FACTOR . 2020: 3.969 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Scopus SIIC Data Bases PubMed/Medline Biological Abstracts Chemical Abstracts Embase Current Contents - Life Sciences EDITORIAL BOARD . Editor-in-Chief C Tsokos, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, CLS-937, 02215, Boston, Massachusetts, United States of America Associate Editors J.S. Chou, Boston Children's Hospital, 02115, Boston, Massachusetts, United States of America M.A. Exley, The University of Manchester, M13 9PL, Manchester, United Kingdom S.J.
    [Show full text]
  • Print Special Issue Flyer
    IMPACT FACTOR 2.430 an Open Access Journal by MDPI Emerging Themes in Host–Pathogen Interactions and Host-Directed Therapies Guest Editors: Message from the Guest Editors Dr. Selvakumar Subbian The last decade has seen a surge in host-directed therapy Public Health Research Institute, for infectious diseases that improve host response to the New Jersey Medical School, Rutgers, The State University of pathogen, target virulence factors, activate the immune New Jersey, Newark, NJ, USA response, and reduce cell/tissue damage leading to [email protected] reduced mortality. Dr. Murugesan Rajaram With due recognition to developments and the importance Assistant Professor, Microbial of host–pathogen interactions and the rise in host-directed Infection and Immunity, Ohio therapy, the Editorial Board of the Medicina has decided to State University, columbus, OH, bring out a Special Issue on “Emerging Themes in Host– USA Pathogen Interactions and Host-Directed Therapies”. This [email protected] Special Issue will be jointly edited by Drs. Selvakumar Dr. Radha Gopalaswamy Subbian, Murugesan Rajaram and Radha Gopalaswamy. Biotechnologist, National We solicit research papers, short commentaries, and Reference Laboratory, reviews on all aspects of this subject area. Department of Bacteriology, National Institute for Research in Keywords: Infectious diseases; Host pathogen interactions; Tuberculosis, Chennai, India Microbial pathogenesis; Intracellular signalling; [email protected] Therapeutic agents; Repurposed drugs; Antibiotics; Immune response; Host-directed therapy; Vaccine; Infection; Virulence determinants Deadline for manuscript submissions: 22 October 2021 mdpi.com/si/56686 SpeciaIslsue IMPACT FACTOR 2.430 an Open Access Journal by MDPI Editor-in-Chief Message from the Editor-in-Chief Prof.
    [Show full text]
  • AMERICAN JOURNAL of INFECTION CONTROL the Official Publication of the Association for Professionals in Infection Control and Epidemiology, Inc
    AMERICAN JOURNAL OF INFECTION CONTROL The Official Publication of the Association for Professionals in Infection Control and Epidemiology, Inc. AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.3 ISSN: 0196-6553 DESCRIPTION . AJIC covers key topics and issues in infection control and epidemiology. Infection control professionals, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC). AJIC is the foremost resource on infection control, epidemiology, infectious diseases, quality management, occupational health, and disease prevention. AJIC also publishes infection control guidelines from APIC and the CDC. AJIC is included in Index Medicus and CINAHL. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center IMPACT FACTOR . 2020: 2.918 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Scopus PubMed/Medline CINAHL Web of Science Science Citation Index Expanded Embase EDITORIAL BOARD . Editor
    [Show full text]
  • Virology Downunder, a Meeting Commentary from the 2019 Lorne Infection and Immunity Conference, Australia Gregor Ebert1,4, Prasad N
    Ebert et al. Virology Journal (2019) 16:109 https://doi.org/10.1186/s12985-019-1217-6 MEETINGREPORT Open Access Virology Downunder, a meeting commentary from the 2019 Lorne Infection and Immunity Conference, Australia Gregor Ebert1,4, Prasad N. Paradkar2 and Sarah L. Londrigan3* Abstract The aim of this article is to summarise the virology content presented at the 9th Lorne Infection and Immunity Conference, Australia, in February 2019. The broad program included virology as a key theme, and the commentary herein highlights several key virology presentations at the meeting. Keywords: Infection, Immunity, Inflammation, Pathogenesis Main text MERS, Marburg and Ebola viruses [1], but remarkably The Lorne Infection and Immunity Conference is one of are able to live asymptomatically with otherwise poten- five scientific meetings held during each month of tially lethal viruses [2]. Wang and colleagues are inter- February in seaside town of Lorne, on the Great Ocean ested in understanding the underlying immune mediated Road in Victoria (Australia). The specific aim of the regulatory mechanisms that facilitate a highly effective meeting is to bring together basic, clinical and transla- balance between viral defense and tolerance in bats as tional researchers - those who examine microbes and viral hosts. their impact on the innate or adaptive immune response, During their evolutionary adaption to effective flight, researchers who study the mechanisms that regulate bats not only developed elevated levels of basal alertness immune responses, and those who apply this knowledge reflected in increased metabolic heart rate and body to preventing and treating infectious and inflammatory temperature, they also seem to have evolved a highly diseases.
    [Show full text]
  • Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies
    Downloaded from orbit.dtu.dk on: Jun 01, 2019 Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies Thakur, Aneesh; Mikkelsen Melvang, Heidi; Jungersen, Gregers Published in: Journal of Immunology Research Link to article, DOI: 10.1155/2019/1356540 Publication date: 2019 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Thakur, A., Mikkelsen Melvang, H., & Jungersen, G. (2019). Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies. Journal of Immunology Research, 2019, [1356540]. https://doi.org/10.1155/2019/1356540 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Hindawi Journal of Immunology Research Volume 2019, Article ID 1356540, 24 pages https://doi.org/10.1155/2019/1356540 Review Article Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies Aneesh Thakur ,1 Heidi Mikkelsen,2 and Gregers Jungersen 2,3 1Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark 2Section for Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark, Kemitorvet, 2800 Kgs.
    [Show full text]